Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medplus Health Services has received two Stay Orders from the appropriate authorities in Nagpur and Amravati (Maharashtra) against an earlier suspension that had been imposed on the company. This update is filed under SEBI Listing Regulations and refers to prior submissions made on August 6 and August 14, 2025. The company has not disclosed the specific nature of the suspension or the authority that issued it. The development is being shared with stock exchanges and will also be posted on the company's website.
Positive for shareholders — the Stay Orders temporarily halt the earlier suspension, allowing Medplus to continue its pharmacy operations in Nagpur and Amravati without disruption. This removes an immediate regulatory overhang on a portion of its store network, though the underlying matter is still pending final resolution.